3B BLACKBIO DX Financial Statement Analysis
|
||
|
The Revenues of 3B BLACKBIO DX have increased by 19.87% YoY .
The Earnings Per Share (EPS) of 3B BLACKBIO DX has increased by 48.59 % YoY. |
||
3B BLACKBIO DX Last 5 Annual Financial Results
[BOM: 532067|NSE : 3BBLACKBIO]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹74 Cr | ₹62 Cr | ₹81 Cr | ₹226,742 Cr | ₹29 Cr |
| Expenses | ₹41 Cr | ₹33 Cr | ₹44 Cr | ₹76,753 Cr | ₹20 Cr |
| Operating Profit (Excl OI) | ₹33 Cr | ₹29 Cr | ₹37 Cr | ₹149,989 Cr | ₹9.32 Cr |
| Other Income | ₹13 Cr | ₹7.26 Cr | ₹6.90 Cr | ₹2,892 Cr | ₹1.60 Cr |
| Interest | ₹0.13 Cr | ₹0.20 Cr | ₹0.11 Cr | ₹228 Cr | ₹0.33 Cr |
| Depreciation | ₹1.06 Cr | ₹0.86 Cr | ₹0.67 Cr | ₹616 Cr | ₹0.54 Cr |
| Profit Before Tax | ₹44 Cr | ₹35 Cr | ₹43 Cr | ₹152,036 Cr | ₹10 Cr |
| Profit After Tax | ₹32 Cr | ₹26 Cr | ₹32 Cr | ₹113,869 Cr | ₹7.69 Cr |
| Consolidated Net Profit | ₹32 Cr | ₹26 Cr | ₹32 Cr | ₹113,869 Cr | ₹7.68 Cr |
| Earnings Per Share (Rs) | ₹55.66 | ₹37.46 | ₹30.28 | ₹42.98 | ₹152.00 |
| PAT Margin (%) | 49.44 | 43.31 | 41.94 | 39.93 | 50.22 |
| ROE(%) | 19.41 | 15.42 | 14.98 | 22.59 | 138.73 |
| ROCE(%) | 26.03 | 21.21 | 20.24 | 29.92 | 179.46 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
Key Financials |
||
| Market Cap | : | ₹ 1,031.3 Cr |
| Revenue (TTM) | : | ₹ 129.0 Cr |
| Net Profit(TTM) | : | ₹ 58.2 Cr |
| EPS (TTM) | : | ₹ 67.6 |
| P/E (TTM) | : | 17.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| 3B BLACKBIO DX | -7.1% | -11.4% | -29.2% |
| LENSKART SOLUTIONS | 7.9% | -5.5% | NA |
| POLY MEDICURE | 10.2% | 8.6% | -36.5% |
| LAXMI DENTAL | 25.6% | 28.1% | -48.6% |
| PREVEST DENPRO | -0.3% | -9.1% | -20.4% |
| NURECA | 0.2% | 1.7% | 8.7% |
3B BLACKBIO DX Revenues
[BOM: 532067|NSE : 3BBLACKBIO]
| Y-o-Y | 19.87 % |
| 5 Yr CAGR | 26.58 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹74 Cr | 19.87 | |
| Mar2024 | ₹62 Cr | -23.32 | |
| Mar2023 | ₹81 Cr | -99.96 | |
| Mar2022 | ₹226,742 Cr | 785,153.07 | |
| Mar2021 | ₹29 Cr | - | |
3B BLACKBIO DX Operating Profit
[BOM: 532067|NSE : 3BBLACKBIO]
| Y-o-Y | 13.30 % |
| 5 Yr CAGR | 37.16 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | 13.30 | |
| Mar2024 | ₹29 Cr | -21.53 | |
| Mar2023 | ₹37 Cr | -99.98 | |
| Mar2022 | ₹149,989 Cr | 1,609,567.29 | |
| Mar2021 | ₹9.32 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -5.50 % |
| 5 Yr CAGR | 8.36 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 44.49% | -5.50 | |
| Mar2024 | 47.08% | 2.35 | |
| Mar2023 | 46% | -30.46 | |
| Mar2022 | 66.15% | 104.99 | |
| Mar2021 | 32.27% | - | |
3B BLACKBIO DX Profit After Tax
[BOM: 532067|NSE : 3BBLACKBIO]
| Y-o-Y | 23.77 % |
| 5 Yr CAGR | 43.00 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | 23.77 | |
| Mar2024 | ₹26 Cr | -19.45 | |
| Mar2023 | ₹32 Cr | -99.97 | |
| Mar2022 | ₹113,869 Cr | 1,483,149.29 | |
| Mar2021 | ₹7.68 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 14.15 % |
| 5 Yr CAGR | -0.39 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 49.44 % | 14.15 | |
| Mar2024 | 43.31 % | 3.27 | |
| Mar2023 | 41.94 % | 5.03 | |
| Mar2022 | 39.93 % | -20.49 | |
| Mar2021 | 50.22 % | - | |
3B BLACKBIO DX Earnings Per Share (EPS)
[BOM: 532067|NSE : 3BBLACKBIO]
| Y-o-Y | 48.59 % |
| 5 Yr CAGR | -22.21 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹56 | 48.59 | |
| Mar2024 | ₹37 | 23.71 | |
| Mar2023 | ₹30 | -29.55 | |
| Mar2022 | ₹43 | -71.72 | |
| Mar2021 | ₹152 | - | |
3B BLACKBIO DX Return on Capital Employed (ROCE)
[BOM: 532067|NSE : 3BBLACKBIO]
| Y-o-Y | 22.73 % |
| 5 Yr CAGR | -38.29 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 26.03% | 22.73 | |
| Mar2024 | 21.21% | 4.79 | |
| Mar2023 | 20.24% | -32.35 | |
| Mar2022 | 29.92% | -83.33 | |
| Mar2021 | 179.46% | - | |
3B BLACKBIO DX Share Price vs Sensex
| Current Share Price | : | ₹1,199.2 |
| Current MarketCap | : | ₹ 1,031.3 Cr |
| Updated EOD on | : | May 22,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| 3B BLACKBIO DX | -7.1% |
-11.4% |
-29.2% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
3B BLACKBIO DX related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 0.2% | 8.8% | 11.4% |
No NSE index found
You may also like the below Video Courses
FAQ about 3B BLACKBIO DX Financials
How the annual revenues of 3B BLACKBIO DX have changed ?
The Revenues of 3B BLACKBIO DX have increased by 19.87% YoY .
How the Earnings per Share (EPS) of 3B BLACKBIO DX have changed?
The Earnings Per Share (EPS) of 3B BLACKBIO DX has increased by 48.59 % YoY .
Check out Intrinsic Value of Peers of 3B BLACKBIO DX
|
Intrinsic Value of LENSKART SOLUTIONS LTD Intrinsic Value of POLY MEDICURE LTD Intrinsic Value of 3B BLACKBIO DX LTD Intrinsic Value of LAXMI DENTAL LTD Intrinsic Value of PREVEST DENPRO LTD |
Compare Stock Analytics of Peers of 3B BLACKBIO DX
LENSKART SOLUTIONS LTD vs POLY MEDICURE LTD vs 3B BLACKBIO DX LTD
LAXMI DENTAL LTD vs PREVEST DENPRO LTD vs
LENSKART SOLUTIONS LTD vs POLY MEDICURE LTD vs 3B BLACKBIO DX LTD
LAXMI DENTAL LTD vs PREVEST DENPRO LTD vs
